DECHRA PHARMACEUTICALS
DECHRA PHARMACEUTICALS
Share · GB0009633180 · 578968 (XLON)
Overview Financial Indicators
No Price
n/a

Current Prices from DECHRA PHARMACEUTICALS

ExchangeTickerCurrencyLast TradePriceDaily Change
XLON: London
London
DPH.L
GBX
15.01.2024 17:38
3.866,00 GBX
0,00 GBX

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 0,00 % - - 0,05 % 0,05 % 41,51 %

Company Profile for DECHRA PHARMACEUTICALS Share

Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. In addition, the company distributes veterinary pharmaceuticals and equipment; offers financial services; markets pet diets; and develops, regulates, manufactures, and markets crop protection. It markets its products through wholesaler and distributor networks. The company operates in the United Kingdom, Germany, rest of Europe, the United States, and internationally. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.

Invested Funds

The following funds have invested in: DECHRA PHARMACEUTICALS invested:

Fund
iShares MSCI UK Small Cap UCITS ETF GBP (Acc)
Vol. in million
7.819,56
Percentage (%)
1,34 %
Fund
iShares FTSE 250 UCITS ETF GBP (Dist)
Vol. in million
19.154,89
Percentage (%)
1,23 %
Fund
iShares STOXX Europe Small 200 UCITS ETF (DE)
Vol. in million
5.600,33
Percentage (%)
0,87 %
Fund
iShares MSCI UK IMI ESG Leaders UCITS ETF GBP (Dist)
Vol. in million
33,93
Percentage (%)
0,63 %

Company Data

Name DECHRA PHARMACEUTICALS
Company Dechra Pharmaceuticals PLC
Website https://www.dechra.com
Primary Exchange XLON London
WKN 578968
ISIN GB0009633180
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - General
CEO Mr. Ian D. Page
Market Capitalization 4 Mrd.
Country United Kingdom
Currency GBP
Employees 2,5 T
Address 24 Cheshire Avenue, CW9 7UA Northwich
IPO Date 2000-09-21
Dividends from 'DECHRA PHARMACEUTICALS'
Ex-Date Dividend per Share
09.03.2023 12,50 GBX
27.10.2022 32,89 GBX
03.03.2022 12,00 GBX
28.10.2021 29,39 GBX
04.03.2021 11,11 GBX
05.11.2020 24,00 GBX
05.03.2020 10,29 GBX
24.10.2019 22,10 GBX
07.03.2019 9,50 GBX
25.10.2018 18,17 GBX

Ticker Symbols

Name Symbol
London DPH.L

More Shares

Investors who DECHRA PHARMACEUTICALS hold also have the following shares in their portfolio:
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Share
AMGEN INC
AMGEN INC Share
ASTRAZENECA PLC
ASTRAZENECA PLC Share
ATKINSREALIS GRP INC.
ATKINSREALIS GRP INC. Share
AUTODESK INC
AUTODESK INC Share
CINTAS CORP
CINTAS CORP Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
EQUITY RESIDENTIAL
EQUITY RESIDENTIAL Share
INTEL CORP
INTEL CORP Share
MICROSOFT CORP
MICROSOFT CORP Share
MULTIQ INTERNATIONAL SK 1
MULTIQ INTERNATIONAL SK 1 Share
PROCTER GAMBLE CORP
PROCTER GAMBLE CORP Share
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025